Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMN 110 in Morquio A syndrome patients with limited ambulation
2011-005703-33Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical Inc.
- Start
- Jan 2012
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of elosulfase alfa in Mucopolysaccharidosis type IV A, sponsored by BioMarin Pharmaceutical Inc.. Started Jan 2012; status: completed.
02
Drugs
elosulfase alfa
03
Conditions
Mucopolysaccharidosis type IV A
Beyond the preview
Go deeper on 2011-005703-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005703-33.